{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-080414","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2026-07-22T20:28:22+00:00","discovered_at":"2026-07-22T20:29:02.287231+00:00","generated_at":"2026-07-22T20:29:09.773576+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Mentari raises additional $200M private placement; extends cash runway into 2029","bullets":["Additional $200M private placement from Fairmount, ADAR1, Venrock, Blackstone, Janus Henderson, and other healthcare investors.","Proceeds extend cash runway into 2029 and through Phase 2a readout for PACAP-targeted programs including MT-002.","Post-merger, pre-Merger Mentari stockholders own ~98.85% of combined company; InMed shareholders ~1.15%; total shares ~601M.","Private placement expected to close immediately prior to merger completion, concurrent with previously announced $290M placement.","Combined company to operate as Mentari Therapeutics and trade on Nasdaq under a new ticker symbol."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-080414","json":"https://secwatch.observer/filing/0001213900-26-080414.json","markdown":"https://secwatch.observer/filing/0001213900-26-080414.md","text":"https://secwatch.observer/filing/0001213900-26-080414.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390026080414/0001213900-26-080414-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390026080414/ea0298644-8k425_inmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-22T20:29:09.773576+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}